Worth reading
66In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
3794000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Large-scale exercise of the 66th Series Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause)
Who receives how much
3,794,000 new shares (from 1 July to 29 July 2026)
EVO FUND (the allottee at the time of issuance on 12 August 2025)
The lower thin line represents the existing number of shares to which these shares will be added.
Terms of the stock acquisition rights
Exercise price
¥84. Details of the exercise price adjustment clause and the adjustment floor were not disclosed in this document.
Number of Stock Acquisition Rights
Total issued: 200,000 warrants. Unexercised: 158,450 as of the end of the preceding month and 120,510 as of 29 July 2026
Most recent equity financing
Timing 12 August 2025 / Type 66th Series Stock Acquisition Rights (with an exercise price adjustment clause), allotted to EVO FUND / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Large-scale exercise of the 66th Series Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) |
| Number of shares to be issued or disposed of | 3,794,000 new shares (from 1 July to 29 July 2026) |
| Intended allottee | EVO FUND (the allottee at the time of issuance on 12 August 2025) |
| Total number of issued shares | 76,434,210 shares (as of the end of the month preceding the subject month) → Not disclosed |
| Exercise price | ¥84. Details of the exercise price adjustment clause and the adjustment floor were not disclosed in this document. |
| Number of Stock Acquisition Rights | Total issued: 200,000 warrants. Unexercised: 158,450 as of the end of the preceding month and 120,510 as of 29 July 2026 |
| Most recent equity financing | Timing 12 August 2025 / Type 66th Series Stock Acquisition Rights (with an exercise price adjustment clause), allotted to EVO FUND / Amount Not disclosed |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because a large-scale exercise of these stock acquisition rights took place. The company has not provided a specific explanation for the reason for the large-scale exercise.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.